News - Page 60 - Psychedelic Alpha

Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Read more about the article Opinions | Why Reinvent the Wheel When You Can Amplify the Effects of Existing Therapy Models?

Opinions | Why Reinvent the Wheel When You Can Amplify the Effects of Existing Therapy Models?

Post published:March 29, 2023
Post category:Opinions

Read more about the article PharmaTher Holdings Announces Update of Type C Meeting with the FDA for KETARX™ (Ketamine) in Parkinson’s Disease

PharmaTher Holdings Announces Update of Type C Meeting with the FDA for KETARX™ (Ketamine) in Parkinson’s Disease

Post published:March 29, 2023
Post category:Press Release

Read more about the article BetterLife’s Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development Article

BetterLife’s Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development Article

Post published:March 29, 2023
Post category:Press Release

Read more about the article Field Trip’s Downfall: Too Early, Too Aggressive, Too Extravagant?

Field Trip’s Downfall: Too Early, Too Aggressive, Too Extravagant?

Post published:March 28, 2023
Post category:Analysis

Read more about the article Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use Disorder

Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use Disorder

Post published:March 28, 2023
Post category:Press Release

Read more about the article Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders Discussing Expansion of Drug Discovery Efforts into Novel Non-Hallucinogenic Therapeutics

Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders Discussing Expansion of Drug Discovery Efforts into Novel Non-Hallucinogenic Therapeutics

Post published:March 28, 2023
Post category:Press Release

Read more about the article Silo Pharma Announces filing of Patent for Treatment of Fibromyalgia

Silo Pharma Announces filing of Patent for Treatment of Fibromyalgia

Post published:March 27, 2023
Post category:Press Release

Read more about the article Reunion Neuroscience Abstract Accepted for Poster Presentation at 2023 ASCP Annual Meeting

Reunion Neuroscience Abstract Accepted for Poster Presentation at 2023 ASCP Annual Meeting

Post published:March 27, 2023
Post category:Press Release

Read more about the article Numinus Launches the Practitioner Certification Pathway – a Complete Psychedelic-Assisted Therapy Training Program

Numinus Launches the Practitioner Certification Pathway – a Complete Psychedelic-Assisted Therapy Training Program

Post published:March 27, 2023
Post category:Press Release

Read more about the article Dispatch from ECNP New Frontiers: Psychedelics (Psychedelic Bulletin #134)

Dispatch from ECNP New Frontiers: Psychedelics (Psychedelic Bulletin #134)

Post published:March 25, 2023
Post category:Psychedelic Bulletin

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.